ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0877

Neutrophils Extracellular Traps Formation May Serve as a Biomarker for Disease Activity in Oligoarticular Juvenile Idiopathic Arthritis

Merav Heshin-Bekenstein1, Szilvia Baron2, Grant Schulert3, Anna Shusterman4, Rachel Shukrun4, Yoav Binenbaum4 and Ronit Elhasid5, 1Dana Dwek Children's Hospital, Tel Aviv Medical Center Israel, Binyamina, Israel, 2Pediatric Hemato-Oncology Research Laboratory, Tel Aviv Medical Center, Tel Aviv, Israel, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Tel Aviv Medical Center, Tel Aviv, Israel, 5Dana Children's Hospital, Tel Aviv Medical Center, Tel Aviv, Israel

Meeting: ACR Convergence 2022

Keywords: Juvenile idiopathic arthritis, neutrophils

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Pediatric Rheumatology – Clinical Poster I: JIA

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, causing significant morbidity. Despite the dramatic improvement in treatment, many patients do not achieve complete remission, and biomarkers for subclinical disease, flares, and response to treatment are lacking. Neutrophils and neutrophil extracellular traps (NETs) were revealed to partake in the pathogenesis of autoimmune and inflammatory conditions, but their role in JIA pathogenesis and as biomarkers for JIA disease activity are largely unexplored. In this study, we aimed to characterize the neutrophil enzymatic activity and NETs in oligoarticular and polyarticular JIA and explored its association with disease activity.

Methods: Neutrophils from 7 patients with oligoarticular and RF negative polyarticular JIA were isolated at the time of diagnosis and after glucocorticoid intraarticular injection with or without DMARD treatment. Enzymatic activity of neutrophil granular enzymes was monitored by colorimetry, while NET formation was assessed using a confocal fluorescence microscope.

Results: In oligoarticular JIA patients (n=4), all disease activity parameters and neutrophil function-related parameters decreased following intraarticular steroid injection. However, only three parameters exhibited statistically significant decline, including Physician Global Assessment (PhGA), Juvenile Activity Disease Activity Score-10 (JADAS-10), and clinical JADAS-10 (cJADAS-10). Importantly, NET formation was strongly positively correlated with the cJADAS-10 at all time points (R=0.93, p=0.007). In polyarticular JIA patients (n=3), neither clinical disease activity parameters, the CRP, or the neutrophil function-related parameters showed consistent and significant decreases after steroid injections. Similarly, there no significant correlation was found between NETs formation and cJADAS-10 in polyarticular JIA patients.

Conclusion: This is the first study exploring the link between NETs formation and JIA activity. In this pilot study, we demonstrated a statistically significant linear correlation between cJADAS-10 and NETs formation in oligoarticular but not in polyarticular JIA patients. Hence, we suggest that NETs might play a role in JIA activity and may serve as a putative biomarker for treatment response. Further work is needed to validate these initial results and determine dynamics of NETosis in JIA.

Supporting image 1

Anti-inflammatory treatment results in NETs formation inhibition. Immunofluorescent staining demonstrating NETs formation in 3 samples: (A) control; (B) an oligo JIA patient at diagnosis; (C) an oligo JIA patient after anti-inflamatory treatment. Images demonstrate a significant increase in NETs formation among JIA patient at diagnosis in comparison to control. In addition, inhibition of NET formation following treatment initiation is shown. White rectangles represent non-NETing neutrophils, while yellow rectangles contain NETing neutrophils


Disclosures: M. Heshin-Bekenstein, None; S. Baron, None; G. Schulert, Novartis, SOBI; A. Shusterman, None; R. Shukrun, None; Y. Binenbaum, None; R. Elhasid, None.

To cite this abstract in AMA style:

Heshin-Bekenstein M, Baron S, Schulert G, Shusterman A, Shukrun R, Binenbaum Y, Elhasid R. Neutrophils Extracellular Traps Formation May Serve as a Biomarker for Disease Activity in Oligoarticular Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/neutrophils-extracellular-traps-formation-may-serve-as-a-biomarker-for-disease-activity-in-oligoarticular-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophils-extracellular-traps-formation-may-serve-as-a-biomarker-for-disease-activity-in-oligoarticular-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology